A detailed history of Nomura Asset Management CO LTD transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Nomura Asset Management CO LTD holds 86,004 shares of REGN stock, worth $64.8 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
86,004
Previous 82,306 4.49%
Holding current value
$64.8 Million
Previous $86.5 Million 4.51%
% of portfolio
0.28%
Previous 0.3%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$1024.09 - $1201.76 $3.79 Million - $4.44 Million
3,698 Added 4.49%
86,004 $90.4 Million
Q2 2024

Aug 14, 2024

BUY
$883.2 - $1071.19 $6.16 Million - $7.47 Million
6,978 Added 9.26%
82,306 $86.5 Million
Q1 2024

May 13, 2024

BUY
$902.69 - $993.35 $14.8 Million - $16.3 Million
16,405 Added 27.84%
75,328 $72.5 Million
Q4 2023

Feb 09, 2024

BUY
$775.18 - $881.7 $1.12 Million - $1.27 Million
1,439 Added 2.5%
58,923 $51.8 Million
Q3 2023

Nov 03, 2023

BUY
$692.45 - $844.37 $1.16 Million - $1.41 Million
1,671 Added 2.99%
57,484 $47.3 Million
Q2 2023

Aug 14, 2023

SELL
$700.03 - $830.35 $1.09 Million - $1.29 Million
-1,556 Reduced 2.71%
55,813 $40.1 Million
Q1 2023

May 11, 2023

SELL
$680.49 - $826.97 $6.59 Million - $8.01 Million
-9,684 Reduced 14.44%
57,369 $47.1 Million
Q4 2022

Feb 14, 2023

SELL
$705.89 - $766.39 $1.52 Million - $1.65 Million
-2,159 Reduced 3.12%
67,053 $48.4 Million
Q3 2022

Nov 10, 2022

SELL
$573.97 - $724.32 $2.89 Million - $3.65 Million
-5,034 Reduced 6.78%
69,212 $47.7 Million
Q2 2022

Aug 12, 2022

BUY
$548.35 - $738.84 $8.05 Million - $10.8 Million
14,676 Added 24.64%
74,246 $43.9 Million
Q1 2022

May 13, 2022

BUY
$595.12 - $698.43 $1.08 Million - $1.27 Million
1,817 Added 3.15%
59,570 $41.6 Million
Q4 2021

Feb 01, 2022

BUY
$543.48 - $670.97 $1.85 Million - $2.29 Million
3,409 Added 6.27%
57,753 $36.5 Million
Q3 2021

Nov 12, 2021

SELL
$574.03 - $680.96 $6.79 Million - $8.06 Million
-11,836 Reduced 17.88%
54,344 $32.9 Million
Q2 2021

Aug 06, 2021

SELL
$472.8 - $558.54 $1.07 Million - $1.26 Million
-2,253 Reduced 3.29%
66,180 $37 Million
Q1 2021

May 14, 2021

BUY
$446.73 - $548.2 $4.39 Million - $5.38 Million
9,818 Added 16.75%
68,433 $32.4 Million
Q4 2020

Feb 12, 2021

BUY
$478.3 - $607.98 $3.48 Million - $4.43 Million
7,283 Added 14.19%
58,615 $28.3 Million
Q3 2020

Nov 12, 2020

BUY
$544.75 - $658.21 $1.57 Million - $1.89 Million
2,873 Added 5.93%
51,332 $28.7 Million
Q2 2020

Aug 13, 2020

BUY
$493.32 - $643.92 $11.5 Million - $15 Million
23,358 Added 93.06%
48,459 $30.2 Million
Q1 2020

May 14, 2020

SELL
$336.18 - $494.43 $316,345 - $465,258
-941 Reduced 3.61%
25,101 $12.3 Million
Q4 2019

Feb 13, 2020

BUY
$274.13 - $376.51 $581,977 - $799,330
2,123 Added 8.88%
26,042 $9.78 Million
Q3 2019

Nov 13, 2019

BUY
$273.46 - $318.39 $791,393 - $921,420
2,894 Added 13.76%
23,919 $6.64 Million
Q2 2019

Aug 13, 2019

SELL
$299.6 - $414.82 $37.3 Million - $51.6 Million
-124,395 Reduced 85.54%
21,025 $6.58 Million
Q1 2019

May 10, 2019

BUY
$372.08 - $439.57 $47.8 Million - $56.5 Million
128,551 Added 762.05%
145,420 $59.7 Million
Q4 2018

Feb 12, 2019

SELL
$335.82 - $403.04 $154,141 - $184,995
-459 Reduced 2.65%
16,869 $6.3 Million
Q3 2018

Nov 07, 2018

SELL
$351.14 - $408.51 $395,383 - $459,982
-1,126 Reduced 6.1%
17,328 $7 Million
Q2 2018

Aug 03, 2018

BUY
$284.6 - $344.99 $146,853 - $178,014
516 Added 2.88%
18,454 $6.37 Million
Q1 2018

May 14, 2018

BUY
$315.82 - $393.78 $137,697 - $171,688
436 Added 2.49%
17,938 $6.18 Million
Q4 2017

Feb 14, 2018

BUY
$358.63 - $469.95 $176,445 - $231,215
492 Added 2.89%
17,502 $6.58 Million
Q3 2017

Nov 13, 2017

BUY
$431.38 - $504.0 $65,138 - $76,104
151 Added 0.9%
17,010 $7.61 Million
Q2 2017

Aug 14, 2017

BUY
N/A
16,859
16,859 $8.28 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $80.7B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Nomura Asset Management CO LTD Portfolio

Follow Nomura Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.